NOBESINE 75 SUSTAINED RELEASE CAPSULE 75MG CAPSULE (SUSTAINED-RELEASE)
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DIETHYLPROPION HYDROCHLORIDE
Available from:
ROUGIER PHARMA DIVISION OF RATIOPHARM INC
ATC code:
A08AA03
INN (International Name):
AMFEPRAMONE
Dosage:
75MG
Pharmaceutical form:
CAPSULE (SUSTAINED-RELEASE)
Composition:
DIETHYLPROPION HYDROCHLORIDE 75MG
Administration route:
ORAL
Units in package:
30/250
Prescription type:
Schedule G (CDSA IV)
Therapeutic area:
Amphetamine Derivatives
Product summary:
Active ingredient group (AIG) number: 0102499001; AHFS:
Authorization status:
MARKETED
Authorization date:
1978-12-31
